Qin et al. [58] reported that in glioblastoma (GBM), a type of microRNA (miR-1258), inhibits pcna transcription by directly targeting e2f1, which provides a new potential target for GBM therapy and other e2f1-driven cancers. The gene discussed is E2F1; the disease is glioblastoma.